Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

HMGA1 Modulates Gene Transcription Sustaining a Tumor Signalling Pathway Acting on the Epigenetic Status of Triple-Negative Breast Cancer Cells.

Penzo C, Arnoldo L, Pegoraro S, Petrosino S, Ros G, Zanin R, Wiśniewski JR, Manfioletti G, Sgarra R.

Cancers (Basel). 2019 Aug 2;11(8). pii: E1105. doi: 10.3390/cancers11081105.

2.

The High Mobility Group A1 (HMGA1) Chromatin Architectural Factor Modulates Nuclear Stiffness in Breast Cancer Cells.

Senigagliesi B, Penzo C, Severino LU, Maraspini R, Petrosino S, Morales-Navarrete H, Pobega E, Ambrosetti E, Parisse P, Pegoraro S, Manfioletti G, Casalis L, Sgarra R.

Int J Mol Sci. 2019 Jun 4;20(11). pii: E2733. doi: 10.3390/ijms20112733.

3.

RPSAP52 lncRNA is overexpressed in pituitary tumors and promotes cell proliferation by acting as miRNA sponge for HMGA proteins.

D'Angelo D, Mussnich P, Sepe R, Raia M, Del Vecchio L, Cappabianca P, Pellecchia S, Petrosino S, Saggio S, Solari D, Fraggetta F, Fusco A.

J Mol Med (Berl). 2019 Jul;97(7):1019-1032. doi: 10.1007/s00109-019-01789-7. Epub 2019 May 10.

PMID:
31076808
4.

A Group Visit for High-Risk Pediatric Asthma Patients: A Quality Improvement Initiative to Improve Asthma Care.

Fallon M, Haynes L, Cadet T, Petrosino S, Cazeau E, Solis J, Cox J, Wu AC, Holder-Niles FF.

Clin Pediatr (Phila). 2019 Jun;58(7):746-751. doi: 10.1177/0009922819839238. Epub 2019 Apr 2.

PMID:
30938184
5.

N-Palmitoylethanolamine-oxazoline (PEA-OXA): A new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion.

Impellizzeri D, Siracusa R, Cordaro M, Crupi R, Peritore AF, Gugliandolo E, D'Amico R, Petrosino S, Evangelista M, Di Paola R, Cuzzocrea S.

Neurobiol Dis. 2019 May;125:77-91. doi: 10.1016/j.nbd.2019.01.007. Epub 2019 Jan 17.

PMID:
30660740
6.

Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease.

Mugnaini C, Rabbito A, Brizzi A, Palombi N, Petrosino S, Verde R, Di Marzo V, Ligresti A, Corelli F.

Eur J Med Chem. 2019 Jan 1;161:239-251. doi: 10.1016/j.ejmech.2018.09.070. Epub 2018 Oct 13.

PMID:
30359820
7.

Tidal and hydrological periodicities of seismicity reveal new risk scenarios at Campi Flegrei caldera.

Petrosino S, Cusano P, Madonia P.

Sci Rep. 2018 Sep 14;8(1):13808. doi: 10.1038/s41598-018-31760-4.

8.

Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis.

Petrosino S, Verde R, Vaia M, Allarà M, Iuvone T, Di Marzo V.

J Pharmacol Exp Ther. 2018 Jun;365(3):652-663. doi: 10.1124/jpet.117.244368. Epub 2018 Apr 9.

PMID:
29632236
9.

Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect.

Petrosino S, Cordaro M, Verde R, Schiano Moriello A, Marcolongo G, Schievano C, Siracusa R, Piscitelli F, Peritore AF, Crupi R, Impellizzeri D, Esposito E, Cuzzocrea S, Di Marzo V.

Front Pharmacol. 2018 Mar 20;9:249. doi: 10.3389/fphar.2018.00249. eCollection 2018.

10.

Anti-Inflammatory and Neuroprotective Effects of Co-UltraPEALut in a Mouse Model of Vascular Dementia.

Siracusa R, Impellizzeri D, Cordaro M, Crupi R, Esposito E, Petrosino S, Cuzzocrea S.

Front Neurol. 2017 Jun 6;8:233. doi: 10.3389/fneur.2017.00233. eCollection 2017.

11.

2-Pentadecyl-2-Oxazoline, the Oxazoline of Pea, Modulates Carrageenan-Induced Acute Inflammation.

Petrosino S, Campolo M, Impellizzeri D, Paterniti I, Allarà M, Gugliandolo E, D'Amico R, Siracusa R, Cordaro M, Esposito E, Di Marzo V, Cuzzocrea S.

Front Pharmacol. 2017 May 30;8:308. doi: 10.3389/fphar.2017.00308. eCollection 2017.

12.

Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome.

Cremon C, Stanghellini V, Barbaro MR, Cogliandro RF, Bellacosa L, Santos J, Vicario M, Pigrau M, Alonso Cotoner C, Lobo B, Azpiroz F, Bruley des Varannes S, Neunlist M, DeFilippis D, Iuvone T, Petrosino S, Di Marzo V, Barbara G.

Aliment Pharmacol Ther. 2017 Apr;45(7):909-922. doi: 10.1111/apt.13958. Epub 2017 Feb 6.

13.

Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis.

Vaia M, Petrosino S, De Filippis D, Negro L, Guarino A, Carnuccio R, Di Marzo V, Iuvone T.

Eur J Pharmacol. 2016 Nov 15;791:669-674. doi: 10.1016/j.ejphar.2016.10.005. Epub 2016 Oct 5.

PMID:
27720681
14.

The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.

Petrosino S, Di Marzo V.

Br J Pharmacol. 2017 Jun;174(11):1349-1365. doi: 10.1111/bph.13580. Epub 2016 Sep 29. Review.

15.

Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders.

Iannotti FA, Di Marzo V, Petrosino S.

Prog Lipid Res. 2016 Apr;62:107-28. doi: 10.1016/j.plipres.2016.02.002. Epub 2016 Mar 7. Review.

PMID:
26965148
16.

Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis.

Petrosino S, Puigdemont A, Della Valle MF, Fusco M, Verde R, Allarà M, Aveta T, Orlando P, Di Marzo V.

Vet J. 2016 Jan;207:85-91. doi: 10.1016/j.tvjl.2015.10.060. Epub 2015 Nov 10.

PMID:
26639824
17.

Exposure to Allergen Causes Changes in NTS Neural Activities after Intratracheal Capsaicin Application, in Endocannabinoid Levels and in the Glia Morphology of NTS.

Spaziano G, Luongo L, Guida F, Petrosino S, Matteis M, Palazzo E, Sullo N, de Novellis V, Di Marzo V, Rossi F, Maione S, D'Agostino B.

Biomed Res Int. 2015;2015:980983. doi: 10.1155/2015/980983. Epub 2015 Mar 19.

18.

Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration.

Pisanti S, Picardi P, Pallottini V, Martini C, Petrosino S, Proto MC, Vitale M, Laezza C, Gazzerro P, Di Marzo V, Bifulco M.

J Cell Physiol. 2015 Dec;230(12):2905-14. doi: 10.1002/jcp.24959.

PMID:
25684344
19.

The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels.

Petrosino S, Schiano Moriello A, Cerrato S, Fusco M, Puigdemont A, De Petrocellis L, Di Marzo V.

Br J Pharmacol. 2016 Apr;173(7):1154-62. doi: 10.1111/bph.13084. Epub 2015 Mar 26.

20.

Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain.

Petrosino S, Ahmad A, Marcolongo G, Esposito E, Allarà M, Verde R, Cuzzocrea S, Di Marzo V.

Pharmacol Res. 2015 Jan;91:9-14. doi: 10.1016/j.phrs.2014.10.008. Epub 2014 Nov 1.

PMID:
25447594
21.

Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.

Borrelli F, Romano B, Petrosino S, Pagano E, Capasso R, Coppola D, Battista G, Orlando P, Di Marzo V, Izzo AA.

Br J Pharmacol. 2015 Jan;172(1):142-58. doi: 10.1111/bph.12907. Epub 2014 Dec 1.

22.

The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels.

Iannotti FA, Silvestri C, Mazzarella E, Martella A, Calvigioni D, Piscitelli F, Ambrosino P, Petrosino S, Czifra G, Bíró T, Harkany T, Taglialatela M, Di Marzo V.

Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):E2472-81. doi: 10.1073/pnas.1406728111. Epub 2014 Jun 3.

23.

Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis.

Abramo F, Campora L, Albanese F, della Valle MF, Cristino L, Petrosino S, Di Marzo V, Miragliotta V.

BMC Vet Res. 2014 Jan 14;10:21. doi: 10.1186/1746-6148-10-21.

24.

The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties.

Rossi F, Bernardo ME, Bellini G, Luongo L, Conforti A, Manzo I, Guida F, Cristino L, Imperatore R, Petrosino S, Nobili B, Di Marzo V, Locatelli F, Maione S.

PLoS One. 2013 Nov 27;8(11):e80022. doi: 10.1371/journal.pone.0080022. eCollection 2013.

25.

Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala.

Blasio A, Iemolo A, Sabino V, Petrosino S, Steardo L, Rice KC, Orlando P, Iannotti FA, Di Marzo V, Zorrilla EP, Cottone P.

Neuropsychopharmacology. 2013 Nov;38(12):2498-507. doi: 10.1038/npp.2013.153. Epub 2013 Jun 24.

26.

Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons.

Cristino L, Busetto G, Imperatore R, Ferrandino I, Palomba L, Silvestri C, Petrosino S, Orlando P, Bentivoglio M, Mackie K, Di Marzo V.

Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):E2229-38. doi: 10.1073/pnas.1219485110. Epub 2013 Apr 29.

27.

Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study.

Abdulnour J, Yasari S, Rabasa-Lhoret R, Faraj M, Petrosino S, Piscitelli F, Prud' Homme D, Di Marzo V.

Obesity (Silver Spring). 2014 Jan;22(1):211-6. doi: 10.1002/oby.20498. Epub 2013 Oct 19.

28.

Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.

Starowicz K, Makuch W, Korostynski M, Malek N, Slezak M, Zychowska M, Petrosino S, De Petrocellis L, Cristino L, Przewlocka B, Di Marzo V.

PLoS One. 2013;8(4):e60040. doi: 10.1371/journal.pone.0060040. Epub 2013 Apr 3.

29.

Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy.

Citraro R, Russo E, Scicchitano F, van Rijn CM, Cosco D, Avagliano C, Russo R, D'Agostino G, Petrosino S, Guida F, Gatta L, van Luijtelaar G, Maione S, Di Marzo V, Calignano A, De Sarro G.

Neuropharmacology. 2013 Jun;69:115-26. doi: 10.1016/j.neuropharm.2012.11.017. Epub 2012 Dec 1.

PMID:
23206503
30.

Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats.

Trezza V, Damsteegt R, Manduca A, Petrosino S, Van Kerkhof LW, Pasterkamp RJ, Zhou Y, Campolongo P, Cuomo V, Di Marzo V, Vanderschuren LJ.

J Neurosci. 2012 Oct 24;32(43):14899-908. doi: 10.1523/JNEUROSCI.0114-12.2012.

31.

Neural precursor cells induce cell death of high-grade astrocytomas through stimulation of TRPV1.

Stock K, Kumar J, Synowitz M, Petrosino S, Imperatore R, Smith ES, Wend P, Purfürst B, Nuber UA, Gurok U, Matyash V, Wälzlein JH, Chirasani SR, Dittmar G, Cravatt BF, Momma S, Lewin GR, Ligresti A, De Petrocellis L, Cristino L, Di Marzo V, Kettenmann H, Glass R.

Nat Med. 2012 Aug;18(8):1232-8. doi: 10.1038/nm.2827. Epub 2012 Jul 22.

32.

Spinal anandamide produces analgesia in neuropathic rats: possible CB(1)- and TRPV1-mediated mechanisms.

Starowicz K, Makuch W, Osikowicz M, Piscitelli F, Petrosino S, Di Marzo V, Przewlocka B.

Neuropharmacology. 2012 Mar;62(4):1746-55. doi: 10.1016/j.neuropharm.2011.11.021. Epub 2011 Dec 8.

PMID:
22178705
33.

TRPV1-dependent and -independent alterations in the limbic cortex of neuropathic mice: impact on glial caspases and pain perception.

Giordano C, Cristino L, Luongo L, Siniscalco D, Petrosino S, Piscitelli F, Marabese I, Gatta L, Rossi F, Imperatore R, Palazzo E, de Novellis V, Di Marzo V, Maione S.

Cereb Cortex. 2012 Nov;22(11):2495-518. doi: 10.1093/cercor/bhr328. Epub 2011 Dec 1.

34.

Effect of the Cannabinoid Receptor-1 antagonist SR141716A on human adipocyte inflammatory profile and differentiation.

Murumalla R, Bencharif K, Gence L, Bhattacharya A, Tallet F, Gonthier MP, Petrosino S, di Marzo V, Cesari M, Hoareau L, Roche R.

J Inflamm (Lond). 2011 Nov 16;8:33. doi: 10.1186/1476-9255-8-33.

35.

Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats.

Deblon N, Veyrat-Durebex C, Bourgoin L, Caillon A, Bussier AL, Petrosino S, Piscitelli F, Legros JJ, Geenen V, Foti M, Wahli W, Di Marzo V, Rohner-Jeanrenaud F.

PLoS One. 2011;6(9):e25565. doi: 10.1371/journal.pone.0025565. Epub 2011 Sep 27.

36.

The endocannabinoid system in cholestasis.

Floreani A, Pizzuti D, Bergasa NV, Petrosino S.

Dig Liver Dis. 2011 Dec;43(12):1026-7. doi: 10.1016/j.dld.2011.05.005. Epub 2011 Aug 3. No abstract available.

PMID:
21816694
37.

Effects of palmitoylethanolamide on the cutaneous allergic inflammatory response in Ascaris hypersensitive Beagle dogs.

Cerrato S, Brazis P, Della Valle MF, Miolo A, Petrosino S, Di Marzo V, Puigdemont A.

Vet J. 2012 Mar;191(3):377-82. doi: 10.1016/j.tvjl.2011.04.002. Epub 2011 May 20.

PMID:
21601500
38.

Inhibition of basal and ultraviolet B-induced melanogenesis by cannabinoid CB(1) receptors: a keratinocyte-dependent effect.

Magina S, Esteves-Pinto C, Moura E, Serrão MP, Moura D, Petrosino S, Di Marzo V, Vieira-Coelho MA.

Arch Dermatol Res. 2011 Apr;303(3):201-10. doi: 10.1007/s00403-011-1126-z. Epub 2011 Feb 5.

PMID:
21298280
39.

Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide.

Scuderi C, Esposito G, Blasio A, Valenza M, Arietti P, Steardo L Jr, Carnuccio R, De Filippis D, Petrosino S, Iuvone T, Di Marzo V, Steardo L.

J Cell Mol Med. 2011 Dec;15(12):2664-74. doi: 10.1111/j.1582-4934.2011.01267.x.

40.

The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy.

Rossi F, Bellini G, Luongo L, Torella M, Mancusi S, De Petrocellis L, Petrosino S, Siniscalco D, Orlando P, Scafuro M, Colacurci N, Perrotta S, Nobili B, Di Marzo V, Maione S; Endocannabinoid Research Group (ERG), Italy.

Bone. 2011 May 1;48(5):997-1007. doi: 10.1016/j.bone.2011.01.001. Epub 2011 Jan 13.

PMID:
21237298
41.

Alteration of the endocannabinoid system in mouse brain during prion disease.

Petrosino S, Ménard B, Zsürger N, Di Marzo V, Chabry J.

Neuroscience. 2011 Mar 17;177:292-7. doi: 10.1016/j.neuroscience.2010.12.046. Epub 2010 Dec 31.

PMID:
21195746
42.

Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.

De Petrocellis L, Ligresti A, Moriello AS, Allarà M, Bisogno T, Petrosino S, Stott CG, Di Marzo V.

Br J Pharmacol. 2011 Aug;163(7):1479-94. doi: 10.1111/j.1476-5381.2010.01166.x.

43.

Possible Anandamide and Palmitoylethanolamide involvement in human stroke.

Naccarato M, Pizzuti D, Petrosino S, Simonetto M, Ferigo L, Grandi FC, Pizzolato G, Di Marzo V.

Lipids Health Dis. 2010 May 14;9:47. doi: 10.1186/1476-511X-9-47.

44.

Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients.

Annuzzi G, Piscitelli F, Di Marino L, Patti L, Giacco R, Costabile G, Bozzetto L, Riccardi G, Verde R, Petrosino S, Rivellese AA, Di Marzo V.

Lipids Health Dis. 2010 Apr 28;9:43. doi: 10.1186/1476-511X-9-43.

45.

Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine.

Guidali C, Viganò D, Petrosino S, Zamberletti E, Realini N, Binelli G, Rubino T, Di Marzo V, Parolaro D.

Int J Neuropsychopharmacol. 2011 Feb;14(1):17-28. doi: 10.1017/S1461145710000209. Epub 2010 Mar 3.

PMID:
20196921
46.

Enhanced cognitive performance of dopamine D3 receptor "knock-out" mice in the step-through passive-avoidance test: assessing the role of the endocannabinoid/endovanilloid systems.

Micale V, Cristino L, Tamburella A, Petrosino S, Leggio GM, Di Marzo V, Drago F.

Pharmacol Res. 2010 Jun;61(6):531-6. doi: 10.1016/j.phrs.2010.02.003. Epub 2010 Feb 10.

PMID:
20149873
47.

The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice.

Costa B, Bettoni I, Petrosino S, Comelli F, Giagnoni G, Di Marzo V.

Pharmacol Res. 2010 Jun;61(6):537-46. doi: 10.1016/j.phrs.2010.02.001. Epub 2010 Feb 6.

PMID:
20138997
48.

The levels of the endocannabinoid receptor CB2 and its ligand 2-arachidonoylglycerol are elevated in endometrial carcinoma.

Guida M, Ligresti A, De Filippis D, D'Amico A, Petrosino S, Cipriano M, Bifulco G, Simonetti S, Orlando P, Insabato L, Nappi C, Di Spiezio Sardo A, Di Marzo V, Iuvone T.

Endocrinology. 2010 Mar;151(3):921-8. doi: 10.1210/en.2009-0883. Epub 2010 Feb 4.

PMID:
20133454
49.

N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities.

Petrosino S, Iuvone T, Di Marzo V.

Biochimie. 2010 Jun;92(6):724-7. doi: 10.1016/j.biochi.2010.01.006. Epub 2010 Jan 21. Review.

PMID:
20096327
50.

FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels.

Petrosino S, Di Marzo V.

Curr Opin Investig Drugs. 2010 Jan;11(1):51-62. Review.

PMID:
20047159

Supplemental Content

Loading ...
Support Center